Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
http://www.tandfonline.com/doi/pdf/10.1517/14712590902763755
Reference117 articles.
1. Virus entry: molecular mechanisms and biomedical applications
2. Passive antibody therapy for infectious diseases
3. Passive Antibody Therapies: Progress and Continuing Challenges
4. Return to the Past: The Case for Antibody-Based Therapies in Infectious Diseases
5. Serum therapy revisited: animal models of infection and development of passive antibody therapy
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mapping immunological and host receptor binding determinants of SARS-CoV spike protein utilizing the Qubevirus platform;Journal of Biological Chemistry;2023-12
2. In silico designing of an epitope-based peptide vaccine cocktail against Nipah virus: an Indian population-based epidemiological study;Archives of Microbiology;2023-11-13
3. Mapping immunological and host receptor binding determinants of SARS-CoV spike protein utilizing the Qubevirus platform;2023-07-28
4. Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus;Heliyon;2023-04
5. Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS‐CoV ‐2 neutralizing monoclonal antibody ABBV‐47D11 in patients with COVID ‐19;Pharmacology Research & Perspectives;2022-12-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3